Review of US registries for psoriasis

被引:5
作者
Amin, Mina [1 ]
No, Daniel J. [2 ]
Wu, Jashin J. [3 ]
机构
[1] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA
[2] Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA
[3] Kaiser Permanente, Los Angeles Med Ctr, Dept Dermatol, 1515 North Vermont Ave,5th Floor, Los Angeles, CA 90027 USA
关键词
Psoriasis; patient registries; clinical trials; post-marketing surveillance; DISEASE-BASED REGISTRY; MYOCARDIAL-INFARCTION RISK; FACTOR INHIBITOR THERAPY; LONGITUDINAL ASSESSMENT; BIOLOGIC AGENTS; PSOLAR; ASSOCIATION; ETANERCEPT;
D O I
10.1080/09546634.2017.1328549
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Patient registries are databases comprised of standardized clinical data for a specific population of patients with a particular disease or medical condition. Information from patient registries allows clinicians to assess long-lasting outcomes in patients with a specific disease, such as psoriasis. Objective: Our primary objective was to identify available psoriasis registries in the United States (U.S.) and evaluate the application of patient registries compared to clinical trials. Methods: We searched Google, the Registry of Patient Registries, Orphanet and ClinicalTrials. gov to create a list of U. S. psoriasis registries. We also performed a literature review on the application of psoriasis registries using PubMed. Results: We identified 6 psoriasis patient registries in the United States. Conclusions: Patient registries are frequently used for psoriasis in the U. S. and provide important information about the safety, efficacy and long-term effects of systemic therapies.
引用
收藏
页码:697 / 701
页数:5
相关论文
共 20 条
[1]   Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009 [J].
Asgari, Maryam M. ;
Wu, Jashin J. ;
Gelfand, Joel M. ;
Salman, Craig ;
Curtis, Jeffrey R. ;
Harrold, Leslie R. ;
Herrinton, Lisa J. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (08) :842-849
[2]   Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis [J].
Bandoli, G. ;
Johnson, D. L. ;
Jones, K. L. ;
Jiminez, J. Lopez ;
Salas, E. ;
Mirrasoul, N. ;
Van Voorhees, A. S. ;
Chambers, C. D. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) :334-339
[3]   Significance of Patient Registries for Dermatological Disorders [J].
de Souza, Mark P. ;
Miller, Vanessa Rangel .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (07) :1749-1752
[4]   Review of patient registries in dermatology [J].
DiMarco, Gabriella ;
Hill, Dane ;
Feldman, Steven R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (04) :824-829
[5]  
Gordon NP., 2006, DOES ADULT KAISER PE
[6]  
Gottlieb AB, 2014, J DRUGS DERMATOL, V13, P1441
[7]   Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR) [J].
Kalb, Robert E. ;
Fiorentino, David F. ;
Lebwohl, Mark G. ;
Toole, John ;
Poulin, Yves ;
Cohen, Arnon D. ;
Goyal, Kavitha ;
Fakharzadeh, Steven ;
Calabro, Stephen ;
Chevrier, Marc ;
Langholff, Wayne ;
You, Yin ;
Leonardi, Craig L. .
JAMA DERMATOLOGY, 2015, 151 (09) :961-969
[8]   Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR) [J].
Kimball, A. B. ;
Leonardi, C. ;
Stahle, M. ;
Gulliver, W. ;
Chevrier, M. ;
Fakharzadeh, S. ;
Goyal, K. ;
Calabro, S. ;
Langholff, W. ;
Menter, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) :137-147
[9]   OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results [J].
Kimball, Alexa B. ;
Rothman, Kenneth J. ;
Kricorian, Gregory ;
Pariser, David ;
Yamauchi, Paul S. ;
Menter, Alan ;
Teller, Craig F. ;
Aras, Girish ;
Accortt, Neil A. ;
Hooper, Michele ;
Rice, Kara Creamer ;
Gelfand, Joel M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) :115-122
[10]   OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis [J].
Kimball, Alexa B. ;
Pariser, David ;
Yamauchi, Paul S. ;
Menter, Alan ;
Teller, Craig F. ;
Shi, Yifei ;
Yong, Mellissa ;
Creamer, Kara ;
Hooper, Michele ;
Aras, Girish ;
Kricorian, Gregory ;
Gelfand, Joel M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (05) :756-764